Company Profile

Othro Therapeutics Inc
Profile last edited on: 2/7/2023      CAGE: 7RZ26      UEI: KSZKASEG8KA5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2016
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1000 Newbury Road Suite120
Thousand Oaks, CA 91320
   (410) 502-6440
   N/A
   N/A
Location: Single
Congr. District: 26
County: Baltimore City

Public Profile

Original author of SBIR application no longer with the firm. Other persons on the team at the time of application appear also to have relocated the firm from Maryland to a California location (using the same name). NIH SBIR funded project appears to organize around exploration of the mechanisms of bone diseases and potential diagnostic methods. The effort is to screen potential novel therapeutic drugs for treatment of bone disease and to develop preclinical experiments for exploring efficacies, safeties, and costs of drugs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $256,486
Project Title: Bone-targeted delivery of TGF? inhibition for osteoarthritis

Key People / Management

  Xu Cao

  Xuchen Aimee Duan

  Nosrat Javidan

  Jian Zhang

Company News

There are no news available.